<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03849625</url>
  </required_header>
  <id_info>
    <org_study_id>Chula-ARC 002/13</org_study_id>
    <nct_id>NCT03849625</nct_id>
  </id_info>
  <brief_title>Characteristics of Patients Diagnosed With NSAID Sensitivity in Thailand</brief_title>
  <official_title>Characteristics of Patients Diagnosed With NSAID Sensitivity in Thailand</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study clinical characteristics and phenotypes of patients diagnosed with NSAID sensitivity in
      Thailand
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Results of skin test/provocation test</measure>
    <time_frame>4 years</time_frame>
    <description>Positive, negative, or equivocal</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Phenotypes of allergic reactions</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine leukotriene E4</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Aspirin Sensitivity</condition>
  <condition>Aspirin-exacerbated Respiratory Disease</condition>
  <condition>Aspirin-Induced Angioedema-Urticaria</condition>
  <condition>Aspirin Allergy</condition>
  <condition>NSAID-Induced Asthma</condition>
  <condition>NSAID-Induced Angioedema-Urticaria</condition>
  <condition>NSAID-Induced Anaphylactoid Reaction</condition>
  <condition>Aspirin-Induced Anaphylactoid Reaction</condition>
  <arm_group>
    <arm_group_label>NSAID sensitivity</arm_group_label>
    <description>Patients diagnosed with an immediate reaction to aspirin/NSAIDs/or paracetamol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>aspirin, NSAIDs, paracetamol</intervention_name>
    <description>Perform skin test and/or provocation test with aspirin, paracetmol, or suspected NSAIDs in questionable cases</description>
    <arm_group_label>NSAID sensitivity</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Sputum, urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients at least 15 years of age with a history of an immediate reaction to
        aspirin/paracetamol, or NSAIDs
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Thai patients with a history of an immediate reaction to aspirin/paracetamol, or
             NSAIDs visiting King Chulalongkorn memorial Hospital

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jettanong Klaewsongkram, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chulalongkorn University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jettanong Klaewsongkram, MD</last_name>
    <email>Jettanong.K@chula.ac.th</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine, Chulalongkorn University</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jettanong Klaewsongkram, MD</last_name>
      <phone>662-2564152</phone>
      <email>Jettanong.K@chula.ac.th</email>
    </contact>
    <investigator>
      <last_name>Jettanong Klaewsongkram, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>February 20, 2019</study_first_submitted>
  <study_first_submitted_qc>February 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2019</study_first_posted>
  <last_update_submitted>July 25, 2019</last_update_submitted>
  <last_update_submitted_qc>July 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Assoc. Prof. Jettanong Klaewsongkram, MD.</investigator_full_name>
    <investigator_title>Assoc. Prof. Jettanong Klaewsongkram, MD.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Asthma, Aspirin-Induced</mesh_term>
    <mesh_term>Angioedema</mesh_term>
    <mesh_term>Urticaria</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

